this double-blind , noncrossover , randomized trial compared high-dose oral and intravenous metoclopramide to standard oral prochlorperazine in emesis caused by doxorubicin [ 70 mg/m2 body surface area ( bsa ) ] and cyclophosphamide ( 700 mg/m2 bsa ) .
C0033229
prochlorperazine
C0042963
emesis